Yap YG - Search Results

1

Lessons from antiarrhythmic trials involving class III antiarrhythmic drugs.

Yap YG, Camm AJ. Yap YG, et al. Am J Cardiol. 1999 Nov 4;84(9A):83R-89R. doi: 10.1016/s0002-9149(99)00707-9. Am J Cardiol. 1999. PMID: 10568665 Review.

2

Prognostic impact of demographic factors and clinical features on the mode of death in high-risk patients after myocardial infarction--a combined analysis from multicenter trials.

Yap YG, Duong T, Bland JM, Malik M, Torp-Pedersen C, Køber L, Connolly SJ, Marchant B, Camm AJ. Yap YG, et al. Clin Cardiol. 2005 Oct;28(10):471-8. doi: 10.1002/clc.4960281006. Clin Cardiol. 2005. PMID: 16274095 Free PMC article.

3

Prognostic value of blood pressure measured during hospitalization after acute myocardial infarction: an insight from survival trials.

Yap YG, Duong T, Bland JM, Malik M, Torp-Pederson C, Køber L, Connolly SJ, Gallagher MM, Camm AJ. Yap YG, et al. J Hypertens. 2007 Feb;25(2):307-13. doi: 10.1097/HJH.0b013e3280115bae. J Hypertens. 2007. PMID: 17211237

4

Potential demographic and baselines variables for risk stratification of high-risk post-myocardial infarction patients in the era of implantable cardioverter-defibrillator--a prognostic indicator.

Yap YG, Duong T, Bland M, Malik M, Torp-Pedersen C, Køber L, Connolly SJ, Gallagher MM, Camm AJ. Yap YG, et al. Int J Cardiol. 2008 May 7;126(1):101-7. doi: 10.1016/j.ijcard.2007.03.122. Epub 2007 May 17. Int J Cardiol. 2008. PMID: 17499864

5

What should we expect from the next generation of antiarrhythmic drugs?

Camm AJ, Yap YG. Camm AJ, et al. Among authors: yap yg. J Cardiovasc Electrophysiol. 1999 Feb;10(2):307-17. doi: 10.1111/j.1540-8167.1999.tb00676.x. J Cardiovasc Electrophysiol. 1999. PMID: 10090237 Review.

6

Relation of ventricular repolarization to cardiac cycle length in normal subjects, hypertrophic cardiomyopathy, and patients with myocardial infarction.

Savelieva I, Yap YG, Yi G, Guo XH, Hnatkova K, Camm AJ, Malik M. Savelieva I, et al. Among authors: yap yg. Clin Cardiol. 1999 Oct;22(10):649-54. doi: 10.1002/clc.4960221011. Clin Cardiol. 1999. PMID: 10526689 Free PMC article.

7

Clinical trials of antiarrhythmic drugs in postmyocardial infarction and congestive heart failure patients.

Camm AJ, Yap YG. Camm AJ, et al. Among authors: yap yg. J Cardiovasc Pharmacol Ther. 2001 Jan;6(1):99-106. doi: 10.1177/107424840100600110. J Cardiovasc Pharmacol Ther. 2001. PMID: 11452341 Review. No abstract available.

8

Potential cardiac toxicity of H1-antihistamines.

Yap YG, Camm AJ. Yap YG, et al. Clin Allergy Immunol. 2002;17:389-419. Clin Allergy Immunol. 2002. PMID: 12113224 Review.

9

Drug induced QT prolongation and torsades de pointes.

Yap YG, Camm AJ. Yap YG, et al. Heart. 2003 Nov;89(11):1363-72. doi: 10.1136/heart.89.11.1363. Heart. 2003. PMID: 14594906 Free PMC article. Review. No abstract available.

10

Optimising the dichotomy limit for left ventricular ejection fraction in selecting patients for defibrillator therapy after myocardial infarction.

Yap YG, Duong T, Bland JM, Malik M, Torp-Pedersen C, Køber L, Gallagher MM, Camm AJ. Yap YG, et al. Heart. 2007 Jul;93(7):832-6. doi: 10.1136/hrt.2006.102186. Epub 2007 Jan 19. Heart. 2007. PMID: 17237132 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters